Day: March 21, 2022
Temecula, CA, March 21, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Hop-on, Inc. (OTC: HPNN) announces and welcomes Elaine Bogart, CPA in her new role as Chief Financial Officer of Digitalage Inc.
After an overwhelming response of exceptional candidate applications, Elaine stood out above the crowd as the right individual we need to execute our rapid growth plans. Elaine is a seasoned industry veteran with deep expertise in media and entertainment, technology, and high-growth and international finance landscapes.
Elaine brings solid experience to Digitalage to help raise the funding needed to begin the exponential growth that is forecasted after launch. Some of Elaine’s previous engagements include but are not limited to Mojix, Shareability, GameShow Network, Deluxe, and Fullscreen. With an aggressive revenue goal for profitability...
PubMatic Expands Leadership Team in EMEA
Written by Customer Service on . Posted in Public Companies.
LONDON, March 21, 2022 (GLOBE NEWSWIRE) — PubMatic (Nasdaq: PUBM), an independent technology company delivering digital advertising’s supply chain of the future, today announced the expansion of its EMEA leadership team further solidifying the company’s commitment to providing local market expertise in the region.
Hitesh Bhatt has been promoted to the role of Senior Director, CTV/OTT, leading the rapidly growing CTV arm of the company’s business. PubMatic’s OTT/CTV global revenue grew by more than six times in the fourth quarter of 2021 over the fourth quarter of 2020 and now monetising OTT/CTV inventory from more than 167 publishers globally. Bhatt will report directly to Emma Newman, CRO, EMEA.
Jacqueline Boakye takes the role of Vice President, Customer Success, EMEA, and is now responsible for the strategic leadership of the...
Adhera Therapeutics Names Preeminent Diabetes Pioneer Dr. Jean Buteau to Scientific Advisory Board
Written by Customer Service on . Posted in Public Companies.
Baton Rouge, LA, March 21, 2022 (GLOBE NEWSWIRE) — Adhera Therapeutics, Inc. (OTCPK: ATRX) (“Adhera” or the “Company”), a clinical stage biopharmaceutical company, is pleased to announce the appointment of Jean Buteau, PhD., to the Company’s Scientific Advisory Board. Dr. Buteau, a published scientist, and award-winning pioneer in the field of diabetes, will lend his expertise and oversight to help advance Adhera’s pipeline, including MLR-1023, the Company’s Phase 2-ready drug candidate as a novel therapeutic for treating Type 1 diabetes (T1D).
MLR-1023 is a next generation, non-PPAR insulin sensitizer via lyn kinase activation that has demonstrated exceptional clinical safety and tolerability in over 700 patients in Phase 2a and 2b diabetes studies. Dr. Buteau has a deep understanding of the mechanism of...
Form 8.3 – AXA INVESTMENT MANAGERS: McKay Securities plc
Written by Customer Service on . Posted in Mergers And Acquisitions.
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser:
AXA Investment Managers S.A.(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree
McKay Securities plc(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position...
PainReform to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th
Written by Customer Service on . Posted in Public Companies.
TEL AVIV, Israel, March 21, 2022 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced it will present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest, on March 28th – 30th from 9:00 a.m. – 5:00 p.m. EDT.
The conference will feature roundtable discussions, fireside chats, and multiple company presentations, including a pre-recorded corporate update from Ilan Hadar, CEO of PainReform. Those who wish to attend must first sign up to become an M-Vest member.
Sign up here to access the presentation.
About PainReform
PainReform is a clinical-stage specialty pharmaceutical company focused on the reformulation...
Jamf Introduces Jamf Fundamentals, a New Plan to Help Growing Small-Midsized Businesses Manage and Secure their Devices
Written by Customer Service on . Posted in Public Companies.
Jamf Fundamentals pairs market-leading, powerful mobile device management technology with new capabilities for protecting, connecting, and empowering small-midsized businesses with Apple
MINNEAPOLIS, March 21, 2022 (GLOBE NEWSWIRE) — Today, Jamf (NASDAQ: JAMF), the standard in Apple Enterprise Management, introduced Jamf Fundamentals, a new plan built for the unique needs of small-midsized businesses. Jamf Fundamentals combines Jamf’s market-leading, powerful mobile device management (MDM) technology with new capabilities for protecting, connecting, and empowering an organization’s end users through malware prevention, password sync, Self Service functionality for Mac, and the ability to deploy any iPad and iPhone app, custom profiles and macOS packages – all designed for simplicity so no additional training is required....
Cellectar Reports Financial Results for Year Ended December 2021 and Provides a Corporate Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
FLORHAM PARK, N.J., March 21, 2022 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of targeted drugs for the treatment of cancer, today announced financial results for the year ended December 31, 2021 and provided a corporate update.
Fourth Quarter and Recent Corporate HighlightsPresented data from 11 multiple myeloma patients from the company’s ongoing Phase 2 CLOVER-1 study of iopofosine I-131 (iopofosine) at the 63rd ASH Annual Meeting and Exposition. The patients included in this report were triple class refractory had a median 7.2 prior lines of therapy, 50% classified as high risk, showed a mean overall response rate (ORR) of 45.5%, clinical benefit rate (CBR) of 72.7% and disease control rate (DCR)...
Artelo Biosciences Reports Four-Month 2021 Financial Results in Connection with its Amended Fiscal Year End and Provides Business Update
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Reports $25.6 Million in Cash and Marketable Securities as of December 31, 2021, Expected to Support Operations Into Second Half of 2023
SOLANA BEACH, Calif., March 21, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today reported financial and operating results for the four month transitional period from September 1, 2021 to December 31, 2021 and provided a business update. The reporting of this four-month period and the concurrent filing of its Form 10-KT reflects the Company’s previously disclosed change in its fiscal year end from August 31 to December 31.
“We achieved a number of important milestones in 2021 and look forward to multiple data readouts in 2022,” stated...
Diana Shipping Inc. Announces Time Charter Contract for m/v Artemis With Cargill
Written by Customer Service on . Posted in Public Companies.
ATHENS, Greece, March 21, 2022 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Cargill International S.A., Geneva, for one of its Panamax dry bulk vessels, the m/v Artemis. The gross charter rate is US$21,250 per day, minus a 4.75% commission paid to third parties, for a period until minimum June 20, 2023 up to maximum August 20, 2023. The charter commenced earlier today. The m/v Artemis was chartered, as previously announced, to Glencore Agriculture B.V., Rotterdam, at a gross charter rate of US$10,250 per day, minus a 5% commission paid to third parties.
The “Artemis” is a 76,942 dwt Panamax dry bulk vessel built in...
oneworld® Alliance Members Plan to Purchase Up To 200 Million Gallons of Sustainable Aviation Fuel Per Year From Gevo
Written by Customer Service on . Posted in Public Companies.
One member has already signed a definitive take-or-pay contract for 30MGPY, worth approximately $800 million across the life of the contract, inclusive of the value from environmental benefits
ENGLEWOOD, Colo., March 21, 2022 (GLOBE NEWSWIRE) — oneworld® Alliance, a network of world-class airlines, and Gevo, Inc. (NASDAQ: GEVO) announced today that certain oneworld members plan to purchase up to 200 million gallons per year of sustainable aviation fuel (“SAF”) from Gevo (the “oneworld Alliance SAF Purchase Goal”). The delivery of the SAF is expected to commence in 2027, for a five-year term.
oneworld members Alaska Airlines, American Airlines, British Airways, Finnair, Japan Airlines and Qatar Airways expect to utilize Gevo’s SAF for their operations in California including San Diego, San Francisco, San Jose and Los Angeles International...